Tacrolimus News and Research

RSS
Tacrolimus is a drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.
UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

Study explores antibody responses following three COVID vaccine doses in kidney transplant recipients

Study explores antibody responses following three COVID vaccine doses in kidney transplant recipients

Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients

Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients

Study examines how race and sex influence tacrolimus pharmacokinetics in kidney transplant recipients

Study examines how race and sex influence tacrolimus pharmacokinetics in kidney transplant recipients

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

SARS-CoV-2 Delta-Omicron recombinant identified in a transplant patient treated with Sotrovimab

SARS-CoV-2 Delta-Omicron recombinant identified in a transplant patient treated with Sotrovimab

Study compares heterologous and homologous third vaccination in kidney transplant recipients

Study compares heterologous and homologous third vaccination in kidney transplant recipients

Study helps understand actionable genetic variation affecting drugs in the Middle East population

Study helps understand actionable genetic variation affecting drugs in the Middle East population

Study assesses the antibody response to additional dose of COVID-19 vaccine in transplant recipients

Study assesses the antibody response to additional dose of COVID-19 vaccine in transplant recipients

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Kidney transplant patients are more susceptible to harmless bacterium, finds study

Kidney transplant patients are more susceptible to harmless bacterium, finds study

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Can an immunosuppressive cancer drug promote SARS-CoV-2 entry into host cells?

Can an immunosuppressive cancer drug promote SARS-CoV-2 entry into host cells?

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

CRISPR screen identifies clinically approved immunosuppressants that could treat coronavirus infections

CRISPR screen identifies clinically approved immunosuppressants that could treat coronavirus infections

Long-term steroid treatment may not be necessary for kidney transplant patients

Long-term steroid treatment may not be necessary for kidney transplant patients

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Patients taking immunosuppressive drugs did not have worse COVID-19 outcomes

Patients taking immunosuppressive drugs did not have worse COVID-19 outcomes